Skip to content
Preprint · OA via OpenAlex

Epigenetic Aging Associations With Psychoneurological Symptoms and Social Functioning in Adults With Sickle Cell Disease

Mitchell R. Knisely, Rita Vanessa Masese, Joacy G. Mathias, Qing Yang, Daniel Hatch, Brandon M. Lê, Faith S. Luyster, Melanie E. Garrett, Paula Jean Tanabe, Nirmish Shah, Allison E. Ashley‐Koch

Biological Research For Nursing · 2024

Abstract

Objective: Sickle cell disease (SCD), the most common inherited blood disorder in the United States, is associated with severe psychoneurological symptoms. While epigenetic age acceleration has been linked to psychoneurological symptom burden in other diseases, this connection is unexplored in SCD. This study aimed to assess the association between epigenetic age acceleration and psychoneurological symptom burden in SCD. Methods: In this cross-sectional study, emotional impact, pain impact, sleep impact, social functioning, and cognitive function were assessed in 87 adults living with SCD. DNA methylation data were generated from blood specimens and used to calculate epigenetic age using five clocks (Horvath, Hannum, PhenoAge, GrimAge, & DunedinPACE). Associations between epigenetic age acceleration and symptoms were assessed. Results: The sample ( N = 87) had a mean (SD) chronologic age was 30.6 (8.1) years. Epigenetic age acceleration was associated with several symptom outcomes. GrimAge age acceleration (β = −0.49, p = .03) and increased DunedinPACE (β = −2.23, p = .004) were associated with worse emotional impact scores. PhenoAge (β = −0.32, p = .04) and the GrimAge (β = −0.48, p = .05) age acceleration were associated with worse pain impact scores. Increased DunedinPACE (β = −2.07 p = .04) were associated with worse sleep impact scores. Increased DunedinPACE (β = −2.87, p = .005) was associated with worse social functioning scores. We did not find associations between epigenetic age acceleration and cognitive function in this sample. Conclusion: Epigenetic age acceleration was associated with worse symptom experiences, suggesting the potential for epigenetic age acceleration as a biomarker to aid in risk stratification or targets for intervention to mitigate symptom burden in SCD.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1177/10998004241250322
Canonical
link ↗
Fetched
2026-10-16 MST

Cite this

APA
Knisely, M.R., Masese, R.V., Mathias, J.G., Yang, Q., Hatch, D., Lê, B.M., Luyster, F.S., Garrett, M.E., Tanabe, P.J., Shah, N., &amp; Ashley‐Koch, A.E. (2024). Epigenetic Aging Associations With Psychoneurological Symptoms and Social Functioning in Adults With Sickle Cell Disease. <em>Biological Research For Nursing</em>. https://doi.org/10.1177/10998004241250322
Vancouver
Knisely MR, Masese RV, Mathias JG, Yang Q, Hatch D, Lê BM, et al. Epigenetic Aging Associations With Psychoneurological Symptoms and Social Functioning in Adults With Sickle Cell Disease. Biological Research For Nursing. 2024. doi:10.1177/10998004241250322.
BibTeX
@unpublished{mitchell2024Epigen, title = {Epigenetic Aging Associations With Psychoneurological Symptoms and Social Functioning in Adults With Sickle Cell Disease}, author = {Mitchell R. Knisely and Rita Vanessa Masese and Joacy G. Mathias and Qing Yang and Daniel Hatch and Brandon M. Lê and Faith S. Luyster and Melanie E. Garrett and Paula Jean Tanabe and Nirmish Shah and Allison E. Ashley‐Koch}, journal = {Biological Research For Nursing}, year = {2024}, doi = {10.1177/10998004241250322}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings